OBJECTIVES: To evaluate initial periodontal treatment effects on gingival crevicular fluid (GCF) interleukin-6 (IL-6), tissue-type plasminogen activator (tPA), plasminogen activator inhibitor-2 (PAI-2), albumin levels in type 2 diabetic patients. DESIGN AND METHODS: GCF samples were collected from 20 type 2 diabetic, 22 non-diabetic non-smokers all with chronic periodontitis at baseline, 1-, 3-months following initial periodontal treatment. Biochemical analysis was performed by ELISA. Data were tested by Mann-Whitney U, Wilcoxon tests. RESULTS: The total amounts of albumin, IL-6, tPA, PAI-2 decreased significantly in diabetics after treatment (1- and 3-months) whereas, only PAI-2 decreased in non-diabetic group at 3-months (p < 0.05). There were statistically significant differences between the diabetics and non-diabetics at all time points for albumin, PAI-2 and at 1-, 3-months for GCF volume (p < 0.050) but only at baseline for IL-6 (p < 0.050). CONCLUSION: Present data suggest clinical improvements are less apparent in diabetic chronic periodontitis patients as reflected by disease markers in GCF and by an increase in concentrations of inflammatory proteins IL-6, tPA, and PAI-2 in GCF of this patient group following initial periodontal treatment.
OBJECTIVES: To evaluate initial periodontal treatment effects on gingival crevicular fluid (GCF) interleukin-6 (IL-6), tissue-type plasminogen activator (tPA), plasminogen activator inhibitor-2 (PAI-2), albumin levels in type 2 diabeticpatients. DESIGN AND METHODS: GCF samples were collected from 20 type 2 diabetic, 22 non-diabetic non-smokers all with chronic periodontitis at baseline, 1-, 3-months following initial periodontal treatment. Biochemical analysis was performed by ELISA. Data were tested by Mann-Whitney U, Wilcoxon tests. RESULTS: The total amounts of albumin, IL-6, tPA, PAI-2 decreased significantly in diabetics after treatment (1- and 3-months) whereas, only PAI-2 decreased in non-diabetic group at 3-months (p < 0.05). There were statistically significant differences between the diabetics and non-diabetics at all time points for albumin, PAI-2 and at 1-, 3-months for GCF volume (p < 0.050) but only at baseline for IL-6 (p < 0.050). CONCLUSION: Present data suggest clinical improvements are less apparent in diabetic chronic periodontitispatients as reflected by disease markers in GCF and by an increase in concentrations of inflammatory proteins IL-6, tPA, and PAI-2 in GCF of this patient group following initial periodontal treatment.
Authors: E Lalla; I B Lamster; M Feit; L Huang; A Spessot; W Qu; T Kislinger; Y Lu; D M Stern; A M Schmidt Journal: J Clin Invest Date: 2000-04 Impact factor: 14.808
Authors: Patricia A A O'Connell; Mario Taba; Auro Nomizo; Maria C Foss Freitas; Flavia A Suaid; Sergio A Uyemura; Glauce L Trevisan; Arthur B Novaes; Sergio L S Souza; Daniela B Palioto; Marcio F M Grisi Journal: J Periodontol Date: 2008-05 Impact factor: 6.993
Authors: Gabriela Alessandra da Cruz; Sergio de Toledo; Enilson Antonio Sallum; Antonio Wilson Sallum; Gláucia Maria Bovi Ambrosano; Janaina de Cássia Orlandi Sardi; Sérgio Eduardo Braga da Cruz; Reginaldo Bruno Gonçalves Journal: J Periodontol Date: 2008-07 Impact factor: 6.993
Authors: Emrah Koçak; Mehmet Sağlam; Seyit Ali Kayış; Niyazi Dündar; Levent Kebapçılar; Bruno G Loos; Sema S Hakkı Journal: Lasers Med Sci Date: 2016-01-11 Impact factor: 3.161
Authors: Virginia M Barnes; Adam D Kennedy; Fotinos Panagakos; William Devizio; Harsh M Trivedi; Thomas Jönsson; Lining Guo; Shannon Cervi; Frank A Scannapieco Journal: PLoS One Date: 2014-08-18 Impact factor: 3.240
Authors: Raed AlRowis; Hani S AlMoharib; Abdulrahman AlMubarak; Jagankumar Bhaskardoss; R S Preethanath; Sukumaran Anil Journal: J Int Oral Health Date: 2014-09
Authors: Jeffrey L Ebersole; Radhakrishnan Nagarajan; David Akers; Craig S Miller Journal: Front Cell Infect Microbiol Date: 2015-08-19 Impact factor: 5.293
Authors: Cátia Reis; Alexandra Viana DA Costa; João Tiago Guimarães; Diana Tuna; Ana Cristina Braga; José Julio Pacheco; Fernando A Arosa; Filomena Salazar; Elsa Maria Cardoso Journal: Exp Ther Med Date: 2014-05-19 Impact factor: 2.447